HCPCS Code C9081
Idecabtagene vicleucel, up to 460 million autologous anti-bcma car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose
| Short Description | Idecabtagene car pos t |
|---|---|
| Year | 2026 |
| Coverage Code | D = Special coverage instructions apply |
| Action Code | N = No maintenance for this code |
| Action Effective Date | January 01, 2022 |
| Code Added Date | October 01, 2021 |
| Pricing Indicator | 53 = Statute |
| Type of Service | 9 = Other medical items or services F = Ambulatory surgical center (facility usage for surgical services) |
Cross Reference: Q2055